GB Sciences, Inc. (OTCMKTS:GBLX – Get Free Report) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.01 and traded as low as $0.00. GB Sciences shares last traded at $0.00, with a volume of 34,148 shares.
GB Sciences Stock Up 100.0 %
The company’s 50 day simple moving average is $0.01 and its 200-day simple moving average is $0.01.
About GB Sciences
GB Sciences, Inc, a phytomedical research and biopharmaceutical drug development company, engages in the research and development of plant-based medicines. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs.
Featured Articles
- Five stocks we like better than GB Sciences
- What Are Dividends? Buy the Best Dividend Stocks
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- How is Compound Interest Calculated?
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- 3 Warren Buffett Stocks to Buy Now
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for GB Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GB Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
